Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study
- PMID: 9748020
- DOI: 10.1212/wnl.51.3.742
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study
Abstract
Background: The major histocompatibility complex (MHC) has been consistently associated with susceptibility to MS and the course of several other human autoimmune diseases. A putative association between the course and severity of MS and the MHC remains controversial.
Methods: DR and DQ genotyping by either restriction fragment length polymorphism or sequence-specific PCR-based typing in 119 patients representing 73.4% of the population with MS evaluated in a cross-sectional disability survey and 100 healthy controls from Olmsted County, Minnesota.
Results: We found a positive association between MS susceptibility and the DR15-DQ6 and DR13-DQ7 haplotypes, and we found a negative association with the DR1-DQ5 haplotype. We found a trend to a positive association of primary progressive MS with DR4-DQ8 and DR1-DQ5 and an association of "bout onset" MS with DR17-DQ2. We did not find an association with disease severity, as defined by EDSS/duration.
Conclusion: Lack of consistency between different studies may be due to regional variation in MS and limitations of power but likely indicate a minor effect of MHC class II genes on the course and severity of MS.
Comment in
-
Major histocompatibility complex class II alleles and the course and outcome of MS.Neurology. 1999 Jun 10;52(9):1923-4. doi: 10.1212/wnl.52.9.1920-c. Neurology. 1999. PMID: 10371558 No abstract available.
-
Major histocompatibility complex class II alleles and the course and outcome of MS.Neurology. 1999 Sep 11;53(4):893-4. doi: 10.1212/wnl.53.4.893. Neurology. 1999. PMID: 10489071 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials